Shuib, S; Wei, WB; Sur, H; Morris, MR; McMullan, D; Rattenberry, E; ... Maher, ER; + view all Shuib, S; Wei, WB; Sur, H; Morris, MR; McMullan, D; Rattenberry, E; Meyer, E; Maxwell, PH; Kishida, T; Yao, M; Latif, F; Maher, ER; - view fewer (2011) Copy Number Profiling in Von Hippel-Lindau Disease Renal Cell Carcinoma. GENE CHROMOSOME CANC , 50 (7) 479 - 488. 10.1002/gcc.20865.
Full text not available from this repository.
Germline mutations in the VHL tumor suppressor gene cause von Hippel-Lindau (VHL) disease and somatic VHL mutations occur in the majority of clear cell renal cell carcinoma (cRCC). To compare copy number abnormalities (CNAs) between cRCC from VHL patients and sporadic cRCC cases without detectable somatic VHL mutations, we analyzed 34 cRCC with Affymetrix 250K arrays. To increase the power of the study, we then combined our results with those of a previously published study and compared CNAs in VHL and non-VHL related cRCC using the genomic identification of significant targets in cancer (GISTIC) program. In VHL, cRCC GISTIC analysis identified four statistically significant regions of copy number gain and four statistically significant regions of deletion that occurred in > 10% of tumors analyzed. Sporadic cRCC without detectable VHL mutations had, on average, more copy number abnormalities than VHL cRCC though the most common regions of loss/gain (e. g., 3p and 14q loss and 5q gain) were present in both tumor sets. However, CNAs on chromosome arms 7p (gain) and 8p (loss) were only detected in VHL RCC. Although individual copy number abnormality peaks contained clear candidate cancer genes in some cases (e. g., the 3p loss peak in VHL cRCC contained only six genes including VHL), most peaks contained many genes. To date, only a minority of the candidate genes included in these peaks have been analyzed for mutation or epigenetic inactivation in cRCC but TNFRSF10C and DUSP4 map to the 8p region deleted in VHL cRCC and TP53 and HIF2A (EPAS1) mapped to CNA loss and gain peaks (chromosomes 17 and 2, respectively) detected in sporadic VHL wild-type cRCC. (C) 2011 Wiley-Liss, Inc.
|Title:||Copy Number Profiling in Von Hippel-Lindau Disease Renal Cell Carcinoma|
|Keywords:||TUMOR-SUPPRESSOR GENE, EPIGENETIC ANALYSIS, ALLELE LOSS, VHL GENE, EXPRESSION, INACTIVATION, METHYLATION, CANCER, GLIOMA, MODEL|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)|
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Child Health > Department of Neurosciences and Mental Health > ICH - Neurosciences Unit
Archive Staff Only: edit this record